Spots Global Cancer Trial Database for idiopathic myelofibrosis
Every month we try and update this database with for idiopathic myelofibrosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors | NCT02440685 | Lymphoma, Large... Lymphoma, Mantl... Lymphoma, Folli... Cancer Neoplasm Tumor Lymphoma, Malig... Lymphoma, B-cel... Lymphoma, Non-H... B-Cell Chronic ... B-Cell Leukemia... B-Lymphocytic L... Chronic Lymphoc... Leukemia, Lymph... Leukemia, Lymph... Myelofibrosis Chronic Idiopat... Idiopathic Myel... Lymphoma, T Cel... Peripheral T-Ce... T-Cell Lymphoma... | ASN002 Dose Esc... ASN002 RD | 18 Years - | Asana BioSciences | |
Familial Myeloproliferative Disorders | NCT00666289 | Polycythemia Ve... Essential Throm... Idiopathic Myel... | 7 Years - | Icahn School of Medicine at Mount Sinai | ||
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome | NCT00475020 | Myelofibrosis | Busulfan Fludarabine Thymoglobulin (... | - 75 Years | M.D. Anderson Cancer Center | |
Correlative Biomarker Study in Patients With Myeloproliferative Disorders | NCT00665067 | Myeloproliferat... Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
Correlative Biomarker Study in Patients With Myeloproliferative Disorders | NCT00665067 | Myeloproliferat... Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis | NCT01433445 | Idiopathic Myel... Post Essential ... Post Polycythem... | panobinostat ruxolitinib | 18 Years - | Novartis | |
Research Tissue Bank | NCT00666549 | Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders | NCT00433862 | Polycythemia Ve... Essential Throm... Idiopathic Myel... Neutrophils Chronic Myelopr... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
Familial Myeloproliferative Disorders | NCT00666289 | Polycythemia Ve... Essential Throm... Idiopathic Myel... | 7 Years - | Icahn School of Medicine at Mount Sinai | ||
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders | NCT00433862 | Polycythemia Ve... Essential Throm... Idiopathic Myel... Neutrophils Chronic Myelopr... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
Research Tissue Bank | NCT00666549 | Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai |